デフォルト表紙
市場調査レポート
商品コード
1572015

全身放射線治療の世界市場

Systemic Radiotherapy

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
全身放射線治療の世界市場
出版日: 2024年10月18日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

全身放射線治療の世界市場は2030年までに11億米ドルに達する見込み

2023年に8億7,660万米ドルと推定される全身放射線治療の世界市場は、分析期間2023-2030年にCAGR 3.9%で成長し、2030年には11億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである病院エンドユースは、CAGR 4.1％を記録し、分析期間終了までに9億1,960万米ドルに達すると予測されています。独立系放射線治療センター（Independent Radiotherapy Centers End-Use）セグメントの成長率は、分析期間中CAGR 3.5％と推定されます。

米国市場は2億3,320万米ドル、中国はCAGR6.0％で成長予測

米国の全身放射線治療市場は、2023年に2億3,320万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR6.0％で、2030年までに2億3,850万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と3.1%と予測されています。欧州では、ドイツがCAGR 3.0%で成長すると予測されています。

全身放射線治療の世界市場：主要動向と促進要因のまとめ

全身放射線治療への注目が高まっている理由とは？

全身放射線治療は、放射性物質を用いて全身のがん細胞を狙い撃ちすることができるため、非常に有効ながん治療の選択肢として注目を集めています。全身放射線治療は、局所的な腫瘍を狙い撃ちする従来の外照射療法とは異なり、放射性同位元素を直接血流に乗せることで、複数の部位に転移したがんを治療することができます。この技術は、甲状腺がん、神経内分泌腫瘍、ある種の骨転移などのがんを治療する際に特に有用です。最も一般的に使用されるアイソトープには、甲状腺がんに使用されるヨウ素131や、神経内分泌腫瘍をターゲットに有望視されているルテチウム177などがあります。放射線は全身に照射されるため、原発巣を越えてがん細胞に到達し、局所的な方法では治療が困難な転移性がんを管理するのに不可欠な手段となります。がん治療が進化し続ける中、全身放射線治療は精密医療の礎石となりつつあり、複雑で広範囲な疾患を抱える患者に希望を提供しています。

全身放射線治療は複雑ながん症例にどのように対応するのか？

全身放射線治療は、より包括的な治療アプローチを必要とすることが多い転移性がんや進行がんの複雑な症例に対応する上で、極めて重要な役割を果たしています。原発巣を越えて転移したがん患者は、局所的な治療ではすべてのがん部位を治療することができないため、重要な課題となります。全身放射線治療では、放射性物質を血流にのせて循環させることで、目に見える腫瘍と画像では検出できないような微細ながん細胞の両方を放射線で狙い撃ちできるようにすることで、この問題に対処しています。例えば、骨に転移した前立腺がんの場合、ラジウム223を含む全身放射線治療は骨転移を特異的に狙い、痛みを和らげ、病気の進行を抑えることができます。同様に、ヨウ素131は、甲状腺がんが肺や骨などの遠隔臓器に転移している場合でも、甲状腺がん患者に高い効果を発揮します。広範ながんを正確に治療する全身放射線治療の能力は、化学療法、手術、局所放射線療法などの他の治療法に代わる、あるいは補助する強力な手段となります。

どのような技術の進歩が全身放射線治療を形成しているのか？

最近の技術の進歩は、全身放射線治療の有効性と安全性を著しく高め、がん治療における全身放射線治療の役割の拡大に貢献しています。最も注目すべき進歩の一つは、放射性医薬品（全身放射線治療で使用される放射性物質）の改良です。これらの物質は現在、より標的を絞り、健康な組織への被曝を最小限に抑えながら、がん細胞に特異的に付着できるようになっています。例えば、ルテチウム177のような放射性同位元素は、がん細胞を探して付着する分子と結合しており、放射線を必要な場所に直接照射することができます。このような標的を絞ったアプローチにより、周囲の健康な組織へのダメージなど、従来放射線療法に伴っていた副作用が軽減されました。もうひとつの重要な進歩は、陽電子放射断層撮影法（PET）や単光子放射断層撮影法（SPECT）などの画像技術の向上です。これにより、医師は放射性医薬品が患者の体内でどのように分布しているかに基づいて治療を調整することができるため、より正確な投与と個別化された治療計画が可能になります。さらに、線量測定の技術革新により、最適な放射線量を計算・照射する能力が向上し、患者にとって効果的かつ安全な治療が保証されるようになった。このような技術的進歩により、全身放射線治療はより広範ながん、特に他の治療法に抵抗性のあるがんにとって、より実行可能で魅力的な選択肢となっています。

全身放射線治療市場の成長を促進する主な要因は？

全身放射線治療市場の成長は、主にがんの罹患率の増加、進行がんや転移がんに対するより効果的な治療法の需要など、いくつかの要因によって牽引されています。がんの罹患率が世界的に上昇を続ける中、局所的な腫瘍だけでなく、広範な転移性疾患もターゲットにできる治療法に対するニーズが高まっています。全身放射線治療は、体の複数の部位に転移したがんに対するソリューションを提供することでこのニーズに対応し、末期がん患者にとって重要な治療選択肢となっています。もう一つの重要な推進力は、個別化医療へのシフトです。個別化医療は、固有の分子マーカーに基づいて特定のがん細胞を標的とする放射性医薬品の開発に拍車をかけた。これにより、全身放射線治療の有効性が大幅に向上する一方、副作用が軽減され、患者にとっても医療従事者にとっても魅力的なものとなっています。さらに、神経内分泌腫瘍の治療に対するルテチウム-177の最近の承認など、新しい放射性医薬品に対する規制当局の承認は、全身放射線治療の潜在的な用途を拡大しています。また、正確な治療計画やモニタリングのために高度な画像技術が使用されるようになってきており、これらのツールによってより正確で個別化された治療が可能になるため、市場の成長にも寄与しています。さらに、高度ながん治療へのアクセスが増加している新興市場では、全身放射線治療に対する認識と採用が高まっています。最後に、がんに罹患しやすい高齢化社会が、がん治療の重要な要素として全身放射線治療の需要をさらに高めています。これらの複合的な要因が全身放射線治療市場を前進させ、がん患者に新たな希望を提供し、この急速に進化する腫瘍学分野のイノベーションを促進しています。

注目の競合他社（全42社）

  • Accuray, Inc.;Advanced Radiotherapy Consulting;Canon Medical Systems Corporation;Carl Zeiss Meditec AG;Centre for Probe Development and Commercialization;Eckert & Ziegler Radiopharma GmbH;Elekta AB;Galera Therapeutics;Hitachi Ltd.;iCAD, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17517

Global Systemic Radiotherapy Market to Reach US$1.1 Billion by 2030

The global market for Systemic Radiotherapy estimated at US$876.6 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$919.6 Million by the end of the analysis period. Growth in the Independent Radiotherapy Centers End-Use segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$233.2 Million While China is Forecast to Grow at 6.0% CAGR

The Systemic Radiotherapy market in the U.S. is estimated at US$233.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$238.5 Million by the year 2030 trailing a CAGR of 6.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Systemic Radiotherapy Market - Key Trends and Drivers Summarized

Why Is Systemic Radiotherapy Garnering Increasing Attention?

Systemic radiotherapy is emerging as a highly effective cancer treatment option, gaining increased attention for its ability to target cancer cells throughout the body using radioactive substances. Unlike traditional external beam radiotherapy, which focuses on specific localized tumors, systemic radiotherapy works by delivering radioactive isotopes directly into the bloodstream, allowing them to travel and treat cancers that have spread to multiple areas. This technique is particularly valuable in treating cancers such as thyroid cancer, neuroendocrine tumors, and certain types of bone metastases. The most commonly used isotopes include iodine-131, used for thyroid cancer, and lutetium-177, which has shown promise in targeting neuroendocrine tumors. Because the radiation is systemic, it reaches cancerous cells beyond the primary tumor site, making it an essential tool for managing metastatic cancers that are difficult to treat through localized methods. As cancer treatment continues to evolve, systemic radiotherapy is becoming a cornerstone of precision medicine, offering hope to patients with complex and widespread disease.

How Does Systemic Radiotherapy Cater to Complex Cancer Cases?

Systemic radiotherapy plays a pivotal role in addressing the complexities of metastatic and advanced-stage cancers, which often require more comprehensive treatment approaches. Patients with cancers that have spread beyond their primary tumor site pose a significant challenge, as localized treatments are not sufficient to target all cancerous areas. Systemic radiotherapy addresses this by circulating radioactive substances through the bloodstream, allowing the radiation to target both visible tumors and microscopic cancer cells that may not be detectable by imaging. For example, in the case of prostate cancer that has metastasized to the bones, systemic radiotherapy with radium-223 can specifically target bone metastases, alleviating pain and reducing the progression of the disease. Similarly, iodine-131 is highly effective for patients with thyroid cancer, even when the cancer has spread to distant organs such as the lungs or bones. Systemic radiotherapy’s ability to treat widespread cancer with precision offers a powerful alternative or adjunct to other treatment modalities like chemotherapy, surgery, or localized radiation therapy, particularly in cases where the cancer is aggressive or has already advanced to later stages.

What Technological Advancements Are Shaping Systemic Radiotherapy?

Recent technological advancements have significantly enhanced the efficacy and safety of systemic radiotherapy, contributing to its expanding role in cancer treatment. One of the most notable developments is the refinement of radiopharmaceuticals—the radioactive substances used in systemic radiotherapy. These substances are now more targeted, allowing them to attach specifically to cancer cells while minimizing exposure to healthy tissues. For instance, radioisotopes like lutetium-177 are bound to molecules that seek out and attach to cancer cells, ensuring that the radiation is delivered directly where it is needed. This targeted approach has reduced the side effects traditionally associated with radiation therapy, such as damage to surrounding healthy tissues. Another critical advancement is the improvement in imaging technologies, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), which allow clinicians to track the distribution of radioactive substances in the body in real time. This enables more precise dosing and personalized treatment plans, as doctors can adjust the therapy based on how the radiopharmaceuticals are distributed in the patient’s body. Additionally, innovations in dosimetry have improved the ability to calculate and deliver optimal radiation doses, ensuring that the treatment is both effective and safe for patients. These technological strides are making systemic radiotherapy a more viable and attractive option for a broader range of cancers, particularly those that are resistant to other forms of treatment.

What Are the Key Factors Driving the Growth of the Systemic Radiotherapy Market?

The growth in the systemic radiotherapy market is driven by several factors, primarily the increasing incidence of cancer and the demand for more effective treatments for advanced and metastatic cancers. As cancer rates continue to rise globally, there is a growing need for therapies that can target not only localized tumors but also widespread metastatic disease. Systemic radiotherapy addresses this need by offering a solution for cancers that have spread to multiple areas of the body, making it a critical treatment option for late-stage cancer patients. Another key driver is the shift toward personalized medicine, which has spurred the development of radiopharmaceuticals that target specific cancer cells based on their unique molecular markers. This has significantly increased the efficacy of systemic radiotherapy while reducing side effects, making it more appealing to both patients and healthcare providers. Additionally, regulatory approvals for new radiopharmaceuticals, such as the recent approval of lutetium-177 for treating neuroendocrine tumors, are expanding the potential applications of systemic radiotherapy. The growing use of advanced imaging technologies for precise treatment planning and monitoring is also contributing to the market’s growth, as these tools enable more accurate and personalized therapies. Moreover, there is a rising awareness and adoption of systemic radiotherapy in emerging markets, where access to advanced cancer treatments is increasing. Lastly, an aging population, which is more susceptible to cancer, is further fueling the demand for systemic radiotherapy as a critical component of cancer care. These combined factors are propelling the systemic radiotherapy market forward, offering new hope for cancer patients and driving innovation in this rapidly evolving field of oncology.

Select Competitors (Total 42 Featured) -

  • Accuray, Inc.;Advanced Radiotherapy Consulting;Canon Medical Systems Corporation;Carl Zeiss Meditec AG;Centre for Probe Development and Commercialization;Eckert & Ziegler Radiopharma GmbH;Elekta AB;Galera Therapeutics;Hitachi Ltd.;iCAD, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Systemic Radiotherapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Propels Growth in Demand for Systemic Radiotherapy Treatments
    • Advancements in Targeted Radiopharmaceuticals Expand Addressable Market for Systemic Radiotherapy
    • Here's How Increasing Adoption of Personalized Medicine Drives Growth in Systemic Radiotherapy
    • Growing Focus on Minimally Invasive Cancer Treatments Strengthens the Business Case for Systemic Radiotherapy
    • Technological Innovations in Radioisotope Delivery Systems Propel Adoption of Systemic Radiotherapy
    • Shift Towards Combination Therapies with Immunotherapy and Chemotherapy Spurs Growth in Systemic Radiotherapy
    • Growing Awareness of Radiopharmaceutical Therapies Generates Demand for Systemic Radiotherapy in Cancer Care
    • Surging Demand for Non-Surgical Cancer Treatment Options Throws the Spotlight on Systemic Radiotherapy
    • Advancements in Nuclear Medicine Technologies Drive Innovation in Systemic Radiotherapy Treatments
    • Expanding Use of Systemic Radiotherapy in Palliative Care Strengthens the Case for Its Adoption in Advanced Cancer Stages
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Systemic Radiotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Systemic Radiotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Systemic Radiotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Independent Radiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Independent Radiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Independent Radiotherapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Systemic Radiotherapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Systemic Radiotherapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Systemic Radiotherapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Systemic Radiotherapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Systemic Radiotherapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Systemic Radiotherapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Systemic Radiotherapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Systemic Radiotherapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Systemic Radiotherapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Systemic Radiotherapy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Systemic Radiotherapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Systemic Radiotherapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Systemic Radiotherapy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Systemic Radiotherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Systemic Radiotherapy by End-Use - Hospitals and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Systemic Radiotherapy by End-Use - Percentage Breakdown of Value Sales for Hospitals and Independent Radiotherapy Centers for the Years 2014, 2024 & 2030

IV. COMPETITION